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Mitigation of exercise-induced stress is of key interest in determining means by which to 
optimize performance horse health.  To this end, dietary interventions that may attenuate 
damaging responses to stress in performance horses have received much attention but have yet to 
be clearly elucidated.  The objective of this study was to test the hypothesis that dietary 
supplementation with a Saccharomyces cerevisiae fermentation product (Original XPC, 
Diamond V Mills, Inc., Cedar Rapids, IA) would decrease markers of exercise-induced stress in 
young horses. Quarter Horse yearlings (mean ± SD; 9 ± 1 mo) were fed a basal diet consisting of 
1.25% BW/d (DM basis) custom-formulated commercial grain split into 2 equal feedings per day 
plus coastal bermudagrass hay ad libitum. Yearlings were balanced by gender, age, BW, and 
farm of origin and randomly assigned to one of two treatment groups: 1) no supplementation 
(CON; n=9), or 2) 21 g/d Saccharomyces cerevisiae fermentation product (10.5 g/feeding; SCFP; 
n=10). After 8 wk of treatment, horses underwent a 2-hr standardized submaximal exercise test 
(SET) on a free stall mechanical exerciser.  Serum was collected before supplementation (wk 0), 
and at wk 8 pre-SET, and 0, 1, and 6 hr post-SET, and evaluated for serum amyloid A (SAA), 
cortisol, and cytokine concentrations by commercial ELISA. Data were analyzed using the 
mixed procedure in SAS v9.4 with repeated measures (time). Diet, time, and the diet × time 
interaction were included as fixed effects and horse(diet) was a random effect. In response to the 
SET at wk 8, SAA increased at 6 hr post-SET in CON (P < 0.0001) but was unchanged through 
6 hr post-SET in SCFP. Serum cortisol increased in both groups immediately after the SET (0 hr 
post-SET; P	≤	0.0005) but returned to pre-SET levels in SCFP by 1 hr post-SET. At 6 hr post-
SET, cortisol in CON had returned to pre-SET concentrations, while SCFP declined to be lower 




dietary supplementation with 21 g/d of SCFP may mitigate stress following prolonged exercise 
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CHAPTER I  
INTRODUCTION  
Performance horse health, particularly health of young horses entering exercise training 
programs, is of utmost importance to maintaining quality of life and performance longevity in 
horses.  Various mechanisms to improve the longevity of performance horses have been 
investigated, including the role of stress-induced immune and inflammatory responses.  
Following a stressor such as exercise, pro- and anti-inflammatory cytokines, acute phase proteins 
(APPs), and stress hormones are released, which are responsible for many of the cardinal signs 
of inflammation, such as pyrexia (Pedersen et al., 2000; Crisman et al., 2008).  Inflammation is 
the body’s protective response to deviations or challenges to tissue homeostasis.  This protective 
response is necessary for stress-induced cellular adaptations but can manifest as swelling, heat, 
pain, and loss of function (Chovatiya et al., 2014), and the resolution of inflammation is essential 
to prevent unnecessary cell damage (Landskron et al., 2014).  Dietary additives, such as 
byproducts of yeast fermentation, have been the focus of several animal and human studies 
because of their potential immune boosting and anti-inflammatory effects (Evans et al., 2012, 
Glade et al., 1990, Morgan et al., 2007, Moyad et al., 2010, Paulsen et al., 2010, Zhu et al., 
2017).  Supplementation with a Saccharomyces cerevisiae fermentation product (SCFP) in rats 
appeared to provide both moderate immune-enhancing and anti-inflammatory benefits, 
demonstrating its potential to favorably modulate immune responses without excessive 
suppression or stimulation of overall immune activity (Evans et al., 2012).  In addition, 
supplementation with SCFP decreased heat stress in rats and broiler chickens (Ducray et al., 
2016, Price et al., 2018). In horses, Saccharomyces cerevisiae fermentation product 





(Wickler 2002) and increased the digestibility of low-quality forage (Morgan et al., 2007).  The 
objective of this study was to evaluate the effects of dietary supplementation of a Saccharomyces 
cerevisiae fermentation product on systemic inflammation and the cellular stress response 
following exercise in young horses.  It was hypothesized that horses receiving the 
Saccharomyces cerevisiae fermentation product would have lower systemic concentrations of 






CHAPTER II  
REVIEW OF THE LITERATURE  
 
The Immune Response 
Multiple systems in the body that work cohesively to promote and sustain the viability of 
overall function.  One mechanism the body employs to detect, prevent, and limit infection is the 
immune system.  The immune system is the body’s defense to prevent or limit infection and 
tissue damage.  Beisel (1999) broadly defined the immune system as all mechanisms and 
responses used by the body to defend itself against foreign substances, microorganisms, toxins, 
and noncompatible living cells. This system can detect when the body is no longer in equilibrium 
by recognizing and reacting to a variety of signals known as danger-associated molecular 
patterns (DAMPs). Disturbances to homeostasis are due to unhealthy cells, which can be affected 
by a range of issues such as infection or cellular damage caused by non-infectious agents like 
acute exercise (Chaplin 2010).  When the immune system first recognizes these signals, it 
responds to address the problem in what is called the immune response, which can be broken 
down into two general categories: the innate immune response and the adaptive immune 
response.  The innate immune system is the dominant immune system response and includes all 
facets of the host’s immune defense mechanisms.  Innate immunity is expressed in a variety of 
ways, from the initial response to physical and chemical stimuli to the coordinated recruitment 
and action of a series of specialized cell populations (Madsen et al., 2014).  Because this system 
makes up the initial host response and the molecules used are expressed broadly on a large 
number of cells, the response activates rapidly after an invading pathogen or toxin is 





of leukocytes (white blood cells), including lymphocytes, granulocytes, monocytes, and 
macrophages.  These cells release many different effector molecules, including cytokines that 
regulate the function of other cells, chemokines that attract inflammatory leukocytes, lipid 
mediators of inflammation, reactive free radical species, and bioactive amines and enzymes that 
also contribute to tissue inflammation (Chaplin 2010).  Local and systemic inflammation is an 
immune response to deviations or challenges to tissue health such as infection, injury, or 
exercise, which allows for the repair of damaged tissue and a return to homeostatic conditions 
(Lamprecht et al., 2008). 
The adaptive immune response is the second set of immune reactions and is a smaller 
response compared to the innate immune response.  It is usually more prominent several days 
after the innate response and is generally expressed temporally.  The adaptive immune response 
is composed of small numbers of cells that have specificity for a particular pathogen, toxin, or 
allergen, and proliferate after encountering their specific noxious stimuli.  These long-lived cells 
can persist in a dormant state but will re-express effector functions rapidly after another 
encounter with their specific antigen (Chaplin 2010).  These adaptive responses are primarily 
located on antigen-specific receptors expressed on T and B lymphocyte surfaces.  In summary, 
the adaptive response manifests an “immune memory,” allowing it to mobilize a more effective 
host response against specific pathogens when they are encountered a second time, even decades 
after the initial sensitizing encounter (Chaplin 2010). 
The innate and adaptive immune systems have often been described as separate systems 
of the host response (Chaplin 2010). However, they usually act together, with the innate response 
representing the first line of host defense and the adaptive response following after several days, 





Components of the innate response contribute to the activation of the adaptive response’s 
antigen-specific cells, and in turn, antigen-specific cells amplify their responses by recruiting 
innate mechanisms to greater control of invading microbes.  In summary, the innate and adaptive 
immune responses are fundamentally different in their mechanisms of action; however, 
cooperation between them is essential for a fully effective immune response. 
Inflammation and the Acute Phase Response 
Inflammation is a biological reaction to a physical stressor which possibly evolved as an 
adaptive response for restoring tissue homeostasis (Medzhitov 2008, Ashley et al., 2012).  Acute 
inflammation is the early (almost immediate) response that is triggered by noxious stimuli and 
conditions, such as infection and tissue injury (Chandrasoma et al., 1998, Medzhitov 2008).  
Acute inflammation may be regarded as the first line of defense against damage and is 
characterized by changes in the microcirculation including exudation of fluid and migration of 
leukocytes from blood vessels to the area of injury (Chandrasoma et al., 1998).  Inflammatory 
reactions involve many pathophysiological processes and cell types.  The primary function of 
localized inflammation is to isolate the underlying source of the disturbance and attract 
specialized cells and their products to the affected area so they can destroy potential pathogens, 
remove damaged tissue, and restore tissue health (Beisel 1999, Ashley et al., 2012).  The healing 
process of inflammation involves the proliferation of fibroblasts, synthesis of collagen, 
phagocytic removal of inflammatory debris, and eventual disappearance of vascular congestion 
and edema (a common physical sign of inflammation; Medzhitov 2008).  The local inflammatory 
response is accompanied by a systemic reaction and dramatic change in liver function known as 
the acute phase response (APR; Ostrowski et al., 1998, Nieman et al., 1999, Pedersen 2000).  





intended to bring defense cells (immune cells) to an affected area, inactivate, and destroy 
invaders.  The APR is also designed to minimize tissue damage, enhance the repair process, and 
restore equilibrium after infection, trauma, or stress and is stimulated when injured cells release 
arachidonic acid metabolites and products of oxidative stress (Chisman et al., 2008).  The APR 
can occur in response to many different types of stressors, such as generalized acute infectious 
illnesses, trauma, severe inflammatory processes, tissue injury, and other medical and surgical 
diseases (Beisel 1995; Cunningham-Rundles et al., 1993; Forse et al., 1994).  The initial 
recognition of infection or injury is mediated by tissue-resident macrophages and mast cells, 
leading to the production of a variety of inflammatory mediators, including cytokines, which are 
released into the circulation by lymphocytes, monocytes, macrophages, and endothelial cells and 
also produced locally in tissues by resident macrophages and other types of cells (Nieman 1999).  
One of the purposes of these mediators is to elicit an inflammatory response locally, allowing 
polymorphonuclear leukocytes (PMN), neutrophils, monocytes, and other cells that are usually 
restricted to the blood vessels to penetrate blood vessel endothelium and enter the area of 
inflammation; this penetration is abetted by the release of chemoattractants (Beisel 1999, 
Medzhitov 2008).  When neutrophils reach the damaged tissue site, they become activated, either 
by direct contact with pathogens or through the actions of cytokines secreted by tissue-resident 
cells and they attempt to kill invading agents by releasing the toxic contents of their granules.  A 
successful acute inflammatory response results in the elimination of the infectious agents 
followed by a resolution and repair phase, which is mediated mainly by tissue-resident and 
recruited macrophages (Medzhitov 2008). However, an ongoing APR or chronic inflammation 
can lead to unnecessary cellular damage and even trigger cellular events that can promote 





Systemic Markers of Stress and Inflammation 
Cytokines 
The acute phase response and inflammation involve a tightly regulated cascade of 
immunological and physiological processes that are coordinated and controlled by immune 
signaling molecules called cytokines which are released both in the blood and locally at the site 
of inflammation (Ostrowski et al., 1998, Beisel 1999, Ashley et al., 2012).  Cytokines facilitate 
an influx of specialized cells which participate in the clearing of antigens and healing of tissue.  
Injection of certain cytokines, such as tumor necrosis factor-a (TNFa), interleukin-1 (IL-1) and 
IL-6, into laboratory animals or humans will produce most, if not all, aspects of the acute phase 
response (Dinarello 1992, Dinarello 1997, Richards et al., 1998, Ostrowski et al., 1999, Pedersen 
et al., 2000).  Although research investigating cytokines in horses is relatively new, the 
fundamental importance of their diverse functions is recognized and acknowledged in human 
studies. 
Cytokines are small peptides that function as intercellular signals and mediators and are 
released from immune cells throughout the body (Beisel 1999).  Cytokines come in numerous 
cell types, such as interferons, ILs, and growth factors, and can be either pro- or anti-
inflammatory in function.  When aseptic and septic inflammatory stimuli activate macrophages 
or monocytes, they quickly respond by producing pro-inflammatory cytokines, which travel via 
the blood to interact with specific receptor proteins located on the walls of target cells throughout 
the body (Beisel, 1995, Jacobsen et al., 2007, Chaplin 2010).  Most cytokines work as monomers 
(a molecule that can be bonded to other identical molecules to form a polymer), although some 
exist as homodimers (IL-10), heterodimers, and trimers (TNFα; Rossio, 1999).  Cytokines act on 





the receptor causes the cellular response by activating an intracellular signal transduction 
pathway. The activation of the signal pathway ultimately leads to induction of new gene 
transcription and acute phase protein (APP) synthesis (Rossio, 1999, Jacobsen et al., 2007, 
Chaplin 2010). Cytokines have diverse functions essential for immune cell growth, activation, 
and function. They promote, sustain, and terminate specific immunological responses that are 
appropriate for the pathogen or antigen toward which the response is directed (Rossio, 1999).  In 
addition to their multiplicity of actions, cytokines tend to have high redundancy, with 
overlapping effects being common, and some cytokines even stimulate the synthesis and release 
of other cytokines (Beisel 1999).  Since most cytokines have multiple functions, and some 
features overlap between different cytokines, they are considered to be highly synergistic and 
highly potent (Nieman 1999). 
Cytokines are frequently divided into two groups and defined as either pro or anti-
inflammatory cytokines.  The ‘pro-inflammatory’ group is broad and includes cytokines such as 
IL-1 and TNF, and the ‘anti-inflammatory’ group includes IL-10.  The pro-inflammatory group 
controls the growth and differentiation of T- and B-lymphocytes (cells that recognize foreign 
materials), initiate APRs, launch immune system activities, trigger central nervous system (CNS) 
responses, and stimulate the release or suppression of hormones (Beisel 1999).  Previous work 
investigating pro-inflammatory cytokines has shown that pro-inflammatory cytokines also 
participate in inflammatory reactions.  Cassatella et al. (1994) reported that TNFa and IL-1b 
were produced by PMN after stimulation with a noxious agonist such as lipopolysaccharide 
(LPS).  Many studies have also shown that injection of TNFa, IL-1b, and IL-6 into laboratory 







Interleukin-1 is part of the pro-inflammatory group of cytokines, which means it helps 
induce the acute phase response (APR) and inflammation.  Interleukin-1 is a polypeptide 
produced by activated macrophages, which facilitates many host defense adaptations to 
environmental and infectious stresses (Cannon et al., 1986).  The biological activities of the two 
isoforms of IL-1, IL-1b and IL-1a, are indistinguishable.  Interleukin-1 upregulates a variety of 
genes, including those that upregulate both its own expression and IL-6, and induces enzymes 
necessary for the synthesis of leukotrienes and prostaglandins (Lamprecht et al., 2008).  
Interleukin-1 affects nearly every cell type, often in concert with another pro-inflammatory 
cytokine, TNFa.  Although IL-1 can upregulate host defenses and function as an 
immunoadjuvant, IL-1 is a highly inflammatory cytokine, and the induction of cyclooxygenase-2 
(PTGS2/COX2) by IL-1 in the central nervous system (CNS) is found to contribute to 
inflammatory pain hypersensitivity (Ren et al., 2009).  Interleukin-1 receptor antagonist (IL-1ra) 
and IL-10 have been found to inhibit and regulate IL-1. 
TNFa 
Tumor necrosis factor alpha (also known as cachectin) is a multifunctional trimer 
cytokine that is mainly secreted by neutrophils, activated T and B lymphocytes, NK cells, 
astrocytes, endothelial cells, and smooth muscle cells.  Tumor necrosis factor a is classified as 
pro-inflammatory and is a component of the acute phase response (APR).  Tumor necrosis factor 
cytokines are part of the family of cytokines that stimulate immune-cell proliferation and 
activation and are critical for activating inflammatory responses (Rossio, 1999).  Tumor necrosis 
factors have a direct or indirect effect that results in the killing of cells bearing foreign antigens, 





1999).  Tumor necrosis factor is also involved in the regulation of a broad spectrum of biological 
processes, including cell proliferation, differentiation, apoptosis, lipid metabolism, and 
coagulation.  Many of the actions produced by TNFa are functionally similar to the effects 
produced by IL-1and has been a target inflammatory mediator investigated in several studies due 
to its central role in the initiation of the immune response to injury or infection (Lamprecht et al., 
2008).  The over-production of TNFa has been implicated in several pathological conditions, 
including fever, cachexia (progressive wasting), septic shock following infection with Gram-
negative bacteria, autoimmune disorders, and meningococcal septicemia (Beisel, 1999, 
Parameswaran et al., 2010). 
IL-6 
Interleukin-6 a cytokine that functions in inflammation and the maturation of B cells and 
is primarily produced at sites of acute and chronic inflammation, where it contributes to host 
defense through the stimulation of acute phase responses, hematopoiesis, and immune reactions.  
After IL-6 is synthesized in the initial stage of inflammation, it moves to the liver through the 
bloodstream, resulting in the rapid induction of the APR and an extensive range of acute phase 
proteins such as C-reactive protein (CRP) and serum amyloid A (SAA; Tanaka et al., 2014).  
Interleukin-6 has been classified as both a pro- and an anti-inflammatory cytokine, as it has 
demonstrated both effects in different studies, but more recent literature suggests that IL-6 has 
mostly regulatory effects during the APR (Pedersen 2000).  Some of the misinterpretations of IL-
6 may stem from the fact that assays used in early studies could not distinguish between IL-1 and 
IL-6 and were thought to have similar functions (Bagby et al., 1996, Ostrowski et al., 1998, 
Ostrowski et al., 1999).  It is now known that IL-6 directly inhibits the expression of TNFa and 





and IL-1b production.  Due to its sometimes conflicting effects, many investigators have found it 
more reasonable to classify IL-6 as an inflammation-responsive cytokine rather than a pro- or 
anti-inflammatory cytokine, since IL-6 does not directly induce inflammation, but increases in 
response to it (Ostrowski et al., 1998, Pedersen 2000, Pedersen et al., 2000, Lamprecht et al., 
2008).  However, similar to IL-1 and TNFa, dysregulated or continual synthesis of IL-6 has a 
pathological effect on chronic inflammation and autoimmunity.  Some of the pathological effects 
of excess IL-6 include, but are not limited to, amyloid A amyloidosis, hypozincemia seen in 
inflammation, and serum iron hypoferremia and anemia associated with chronic inflammation.  
IL-6 can also induce the excess production of vascular endothelial growth factor (VEGF) which 
can lead to enhanced angiogenesis and increased vascular permeability, which are pathological 
features of inflammatory lesions seen in synovial tissues of rheumatoid arthritis (RA; Tanaka et 
al., 2014). 
IL-10 
A number of different mechanisms can also inhibit the effects of cytokines, including 
anti-inflammatory cytokines.  These cytokines are vital in the control of immune reactions by 
limiting the extent of the inflammatory response. For example, anti-inflammatory cytokines may 
terminate the immune and inflammatory response when the noxious stimuli have been removed 
(Rossio, 1999).  Cytokines with inhibitory actions can also block the synthesis and release of 
other cytokines. Target cells release cytokine receptors into the plasma, and these soluble free 
receptors will intercept and inactivate the cytokine before it reaches the target cell. Additionally, 






Interleukin-10 is a homodimer and is classified as an anti-inflammatory cytokine (Rossio, 
1999).  Interleukin-10 has been shown to inhibit the release of TNFa and IL-1 and induces the 
production of IL-1ra (Jenkins et al., 1994; Cassatella et al., 1994, Chernoff et al., 1995, 
Ostrowski et al., 1999).  Chernoff et al. (1995) demonstrated that a single intravenous injection 
of IL-10 was safe in humans, had an inhibitory effect on T cells, and it suppressed the production 
of the pro-inflammatory cytokines, TNFa and IL-1b.  Furthermore, the half-life of IL-1ra 
mRNA was prolonged in the presence of IL-10 (Chernoff et al., 1995).  A study conducted by 
Cassatella et al. (1994) showed that IL-10 selectively upregulated IL-1ra production in LPS-
activated PMN, while it inhibited the production of IL-1b and TNFa.  This study suggested that 
IL-10 may be an important physiologic regulator of cytokine production from PMN and 
emphasizes the potential role of IL-10 in inflammatory responses.  Another study by Jenkins et 
al. (1994) showed similar results and concluded that the net effects of IL-10 on inflammatory 
cells might have a substantial role in the modulation of biologic responses to IL-1. 
Even though little research exists investigating the role of cytokines in horses, human 
studies have shown that inflammatory cytokines play a crucial role in the development of 
inflammatory responses.  There have been many studies investigating the activities of cytokines 
due to the desire to mitigate/control inflammation following a stressor (Rossio, 1999).  Even 
though cytokine-induced responses are generally protective in nature, excess production or 
activity of cytokines can be harmful.  In fact, dysregulation of the inflammatory response 
resulting in excessive production of pro-inflammatory cytokines or their production in the wrong 
biological context may lead to chronic inflammation, which is detrimental to a horse’s welfare 
(Lamprecht et al., 2008).  Because most studies studying the role of cytokines are in humans, 






A vital component of the APR includes the release of hormones.  During injury or illness, 
as well as other forms of stress, communication between the brain and immune system is crucial 
(Smith 2003).  By definition, a hormone is a signaling molecule that regulates and coordinates 
physiologic and metabolic functions by acting on receptors located on or in target tissues 
(McKeever et al., 2014).  Hormones play an essential role in the immune and inflammatory 
responses that make up the APR and can act as biomarkers that can quantitatively characterize 
the APR.  One hormonal biomarker typically measured is the hormone, cortisol, which is the 
primary glucocorticoid produced and secreted by the adrenal cortex.  
Cortisol is a well-documented marker of stress in both humans and horses, and it is often 
referred to as the “stress hormone” due to its involvement in the stress response (e.g., affecting 
blood pressure, blood sugar, and other stress adaptations; Hannibal et al., 2014).  The biological 
roles of cortisol fall into two major categories: substrate mobilization and immune modulation.  
Immunologically, cortisol functions as an anti-inflammatory mediator and plays a role in 
hypersensitivity, immunosuppression, and disease resistance (Hannibal et al., 2014).  
Furthermore, the release of glucocorticoids like cortisol modulates the intensity of the acute 
phase response, virtually all of whose components are inhibited by glucocorticoids, including 
cytokine production.  The secretion of many inflammatory mediators by activated lymphocytes 
and macrophages is also inhibited (Nieman 1999).  Once released, cortisol is taken up by a 
variety of tissues throughout the body, such as skeletal muscle, adipose tissue, and the liver.  At 
these different tissues, the presence of cortisol mediates critical physiological processes which 
aid in stress recovery.  Nieman (1999) described the pituitary-adrenal response to stress (i.e., the 





response to toxins, antigens, injury, and invading organisms.”  Nieman explained that this is an 
essential biological function that serves as a balance to inflammatory reactions, as intense 
mobilization of cytokines and inflammatory mediators can potentially be fatal (Nieman, 1999). 
The anti-inflammatory and immunosuppressive effects of cortisol have been well 
documented in both humans and horses (Smith 2003, Hannibal et al., 2014).  A study in humans 
demonstrated that cortisol treatment decreased pro-inflammatory cytokine levels in the blood 
(TNFa IL-1b, and IL-6; Derijk et al., 1997, Pedersen 2000, Starkie et al., 2005, Edwards et al., 
2006) as well as suppressed their actions (Smith, 2003).  The immunosuppressive/anti-
inflammatory effects of cortisol have been also shown to prevent the migration of leucocytes 
from circulation into extra-vascular fluid spaces, reduce the accumulation of monocytes and 
granulocytes at inflammatory sites, and inhibiting lymphocyte and leucocyte proliferation, 
migration, and cytotoxicity (Pedersen et al., 2000, Smith, 2003, Hannibal et al., 2014).  Pedersen 
et al. (2000) also described a study in which corticosteroids given intravenously to humans 
caused lymphocytopenia, monocytopenia, eosinopenia, and neutrophilia that reach their 
maximum 4 h after administration. 
Cortisol serves as a signal for cellular repair following a stressor, such as tissue damage 
after exercise (Davitt et al., 2014), which may elicit a permissive effect that is beneficial for 
training adaptation by preventing the immune system from stimulating an excessive 
inflammatory and immune reaction to acute exercise (Smith 2003, Edwards et al., 2006, 
McKeever et al., 2014).  However, stress hormones such as cortisol are also shown to suppress 
macrophage and NK cell function, both of which are intimately involved in cell-mediated 





unresolved increases in cortisol in the blood may lead to decreased protection against 
intracellular pathogens, resulting in an increased incidence of infection (Smith, 2003). 
Serum Amyloid A 
The APR also includes the release of acute phase proteins (APPs) such as serum amyloid 
A (SAA).  Much interest has been concentrated on APPs as potential indicators of the presence, 
degree, and time course of inflammation in recent decades.  The production of APPs occurs in 
the liver and is mediated by the pro-inflammatory cytokines IL-1, IL-6, and TNFα, and secreted 
by the phagocytic cells in response to various types of tissue damage and the induction of the 
APR (Tarto et al., 2015).  The key benefit to APPs as a marker of inflammation is that they have 
very low or undetectable levels in the plasma of healthy individuals.  However, during the APR, 
plasma concentrations of APPs increase more than 10x, and sometimes 100x or 1000x, but a 
short half-life allows APPs to very quickly return to base levels as the acute stress recedes 
(Badolato et al., 1994, Jacobsen et al., 2007, Crisman et al., 2008, Turło et al., 2015a, Turło et 
al., 2015b).  Serum amyloid A is one of the only identified and main major APP in the horse to 
date (Jacobsen et al., 2007).  Serum Amyloid A is considered one of the more sensitive APPs and 
the literature has shown it to be a relatively accurate potential marker of subclinical inflammation 
or even microtrauma (McGowan et al., 2014, Turło et al., 2015a, Turło et al., 2015b).  Serum 
amyloid A is an acute phase protein that is bound to high-density lipoproteins in the blood and 
secreted mainly by hepatocytes during the APR (Badolato et al., 1994).  Modest, but noteworthy 
increases of SAA have been detected after a stressor such as strenuous exercise, heat stroke, and 
parturition, with a response time starting around 6 to 12 h after the stimulus and a peak at 48 h 
(Jacobsen et al., 2007, Crisman et al., 2008).  The short half-life causes plasma SAA levels to 





al., 2007, Turło et al., 2015a).  The characteristics of APPs mean that their concentrations are 
directly related to the severity of the underlying condition and can provide an objective measure 
of the severity and extent of the underlying condition (Chrisman et al., 2008, Turło et al., 2015a). 
The physiologic roles of SAA are not entirely understood (Badolato et al., 1994), because 
various effects have been reported.  The effects seen include enhancement or inhibition of 
leukocyte functions, chemotactic recruitment of inflammatory cells to the site of infection, 
inhibition of lymphocyte and endothelial cell proliferation, and inhibition of platelet aggregation. 
Other effects seen are phagocytosis (the ingestion of bacteria or other materials by phagocytes 
and amoeboid protozoans), lipid transportation to inflamed tissues, and the induction of enzymes 
involved in degradation of extracellular matrix (i.e.,  metalloproteinases, collagenases; Badolato 
et al., 1994).  When subcutaneously injected into mice, SAA recruited PMN cells and monocytes 
at the injection site, which suggested that SAA may participate in enhancing the migration of 
monocytes and PMN to inflamed tissues during an APR (Badolato et al., 1994).  Serum amyloid 
A was also shown to inhibit myeloperoxidase release and modulate connective tissue breakdown 
in normal remodeling.  These various effects observed suggest a ‘housekeeping’ role for the 
protein by providing a rapid defense against tissue injury from inflammatory conditions 
(Jacobsen et al., 2007, Crisman et al., 2008).  However, when high-level concentrations of SAA 
persist for an extended period, serious complications and chronic inflammatory diseases may 
generate amyloid A amyloidosis, causing amyloid fibril deposition, which in turn causes 
progressive deterioration in various organs (Tanaka et al., 2014). 
Acute phase proteins are being increasingly used as markers for identifying inflammation 
and monitoring response to treatment in horses.  Use of APPs in veterinary medicine is becoming 





Serum amyloid A is the main acute phase protein (APP) in horses and is released into the 
bloodstream in the initial phase of inflammation and the APR (Tarto et al., 2015).  The literature 
shows that in horses affected by inflammatory disorders of the gastrointestinal, respiratory and 
reproductive systems or in horses that develop complications after surgical procedures, SAA 
levels can exceed the physiological range from 10 to 1000 times which may be useful in disease 
diagnostics and prognostication (Jacobsen et al., 2005, Jacobsen et al., 2007, Canisso et al., 
2014).  The low or undetectable SAA levels in healthy horses, rapid and significant increase in 
plasma levels after an inflammatory stimulus, and the short half-life allow the course of 
inflammation to be monitored efficiently (Jacobsen et al., 2007).   
Exercise as a Stressor 
The immune response to exercise has been investigated in numerous studies, and 
similarities between exercise-induced and disease-related immune changes have been 
documented (Lamprecht et al., 2008).  There is a great deal of research on the inflammatory 
response to exercise in human athletes because stress and inflammation have traditionally been 
associated with fatigue and impaired recovery from exercise (Liburt et al., 2010).  However, less 
information is available regarding the inflammatory response to exercise in horses undergoing 
training.  In humans and dog trials, a reaction analogous to the APR has been described after 
prolonged or strenuous exercise (Cywińska et al., 2012). 
When at rest, the horse’s internal environment can maintain homeostasis relatively easily.  
However, the introduction of work or exercise has the potential to disrupt internal balance and 
become a physiologic challenge that invokes an integrative response from multiple organ 
systems (Pedersen et al., 2000, McKeever, 2002, McKeever et al., 2014).  Exercise induces 





acute immune response to exercise, including changes in stress hormones and cytokine 
concentrations, body temperature changes, increases in blood flow, APP mobilization, and 
dehydration (Nieman 1999, Pedersen et al., 2000).  Exercise, even in healthy individuals, is 
shown to lead to a robust inflammatory response characterized by mobilization of leukocytes and 
an increase in their numbers in the central circulation, an increase in circulating potent 
inflammatory mediators like IL-6, production of stress hormones such as cortisol, and the 
accumulation of APPs (Cooper et al., 2007, Crisman et al., 2008, Horohov et al., 2012).  Even 
brief exercise can elicit an immune and inflammatory response (Cooper et al., 2007), but longer 
or progressively more intense work causes more systemwide alterations, which require integrated 
whole-body responses that involve neural and endocrine mediation (McKeever et al., 2014).  
Exercise can elicit an immunological “danger” type of stress and inflammatory response 
(Matzinger et al., 2001, Cooper et al., 2007) that is quantifiable and reproducible, can be 
modified experimentally, and thus considered as a prototype of stress.  The immune system’s 
response to strenuous exercise in humans is thought to mirror the immunological changes seen in 
response to clinical stressors such as surgery, trauma, and sepsis.  Therefore, inducing exercise 
stress gives the ability to observe the different immune and inflammatory responses to stressors 
(Gleeson 2000, Pedersen, 2000, Edwards et al., 2006).  Several factors, including the modality, 
intensity, and duration of exercise, influence the inflammatory response (Lamprecht et al., 2008).  
Even brief exercise can elicit an immune and inflammatory reaction that can induce immune 
changes for several hours, but longer or progressively more intense work causes more 
systemwide alterations that may last at least 24 h (Pedersen 2000, Cooper et al., 2007, McKeever 





The concept of immunosuppression in athletes following exercise has been investigated 
in many contemporary studies.  Overtraining syndrome (OTS) is a term for when an athlete is 
training vigorously, yet performance deteriorates.  One sign of OTS is suppressed immune 
function, with an increased incidence of upper respiratory tract infection (URTI; Smith, 2003).  
An increased incidence of URTIs has been associated with long duration or high-intensity 
training, such as a marathon, as well as with excessive/eccentric exercise (Smith, 2003).  Nieman 
(1999) proposed that the relationship between exercise and URTI may be modeled in the form of 
a J-curve. This "J"-shaped model of relationship between varying amounts of exercise and risk of 
URTI. This model suggests that moderate exercise may lower risk of respiratory infection while 
excessive amounts may increase the risk (Nieman 1999). This model suggests that although 
moderate exercise training may decrease the risk of infection or illness when compared to a 
sedentary lifestyle, chance may rise above average during periods of excessive amounts of high-
intensity exercise. However, it should be noted that more research using larger subject pools with 
improved research designs is necessary before this model can be accepted or rejected.  
Recent studies have suggested that the exercise-associated induction of apoptosis 
(controlled cell death) may contribute to lymphocytopenia (abnormally low levels of 
lymphocytes in the blood) which could contribute to reduced immunity after intense exercise 
(Pedersen et al., 2000).  Additionally, the lengthier and more intense the exercise bout (e.g., 
marathon) the more extensive and prolonged the immune and inflammatory response. This is 
supported with studies showing moderate exercise bouts (< 60% maximal aerobic power and < 
60 min duration) evoking little change from resting levels (Nieman 1999).  However, training 
sessions in horses can sometimes last over 60 min, especially in competitions, and therefore may 





system is suppressed following prolonged endurance exercise or high-intensity exercise, which 
decreases host protection (Nieman 1999). 
Markers of Stress and Inflammation in Response to Exercise 
Identifying markers of systemic and cellular stress and inflammation remains a popular 
topic in both human and animal studies because of a desire to control post-exercise stress and 
mitigate the associated inflammation.  In human athletes, consequences related to increased 
expression of inflammatory mediators post-exercise can range from mild symptoms of delayed- 
onset muscle soreness to more debilitating problems related to soft tissue, joint, and bone 
damage (MacIntrye et al., 1995, Smith 2004, Lamprecht et al., 2008, Liburt et al., 2010, Horohov 
et al., 2012).  Equine athletes, like their human counterparts, suffer from challenges related to 
exercise.  Although the causes of lameness are varied, increased attention has been focused on 
the role of inflammatory mediators in this process (Horohov et al., 2012).  Exercise-induced 
inflammation is a common problem in the equine athlete, resulting in impaired health, lost 
training time, and millions of dollars in veterinary expenses in the equine industry per year 
(Lamprecht et al., 2008).  Injuries of bone, muscle, and tendon resulting from repetitive 
mechanical overload are some of the primary health issues in performance horses and are 
responsible for a considerable number of lost training days in racehorses (Dyson et al., 2008). 
Early recognition of horses at risk of suffering the injury is crucial and the range of blood 
biomarkers have been examined in that context (Turło et al., 2015a) A study conducted with 2- 
and 3-year-old racing Thoroughbreds by Frisbie et al. (2010) investigated seven serum 
biomarkers for the detection of musculoskeletal  injuries.  A unique biomarker pattern occurred 
before each type of injury investigated and was beneficial in classifying horses as injured or 





screening aid prior to a musculoskeletal  injury (Frisbie et al., 2010).  Work with biomarkers has 
shown promise both in man and in horses for assessing musculoskeletal  stress, but further study 
to evaluate biomarker levels horses is required as most work has mainly focused on bone and 
joint tissues (Ray et al., 1996; Poole 1997; Frisbie et al., 2008, Frisbie et al., 2010).  Properly 
understood biomarkers could lead to early recognition of injury, identification of overtraining, 
and easier monitoring of recovery progression. Identified systemic biomarkers of stress and 
inflammation in horses include, but are not limited to, cortisol, SAA, pro-inflammatory cytokines 
(IL-1α/b and TNFα), inflammatory responsive cytokine IL-6, and anti-inflammatory cytokines 
(IL-10). 
Cytokines 
Exercise, even in healthy individuals, leads to a robust inflammatory response 
characterized by mobilization of cytokines and an increase in their concentrations in the central 
circulation (Cooper et al., 2007).  Exercise-induced microdamage and stress stimulate a complex 
cascade of non-specific events known as the inflammatory response, which allows the body to 
restrict tissue damage to the site of the damage.  This local response involves the production of 
cytokines that are released at the site of inflammation, including IL-1, IL-6, and TNFα, which are 
the cytokines that have been most extensively studied in response to exercise.  The first study 
suggesting that exercise provoked a cytokine response reported that plasma obtained from human 
subjects after exercise, and injected intraperitoneally into rats, elevated rectal temperature 
(Cannon et al., 1983, Pedersen et al., 2000).  Human studies then showed an upregulated pro-
inflammatory cytokine or APR to intense exercise along with a small anti-inflammatory 
response.  Contemporary studies have shown that even local musculoskeletal  (work-related) 





inflammation (Cooper et al., 2007).  It should be noted that even though many studies have and 
still are investigating the response of cytokines after exercise, the results of those studies are 
inconsistent and sometimes conflicting, only agreeing that cytokine levels increase in some way 
after eccentric exercise (Pedersen 2000). 
IL-1 
Increases in IL-1(a/b) in the blood following exercise have been reported primarily in 
studies where the exercise is long term, such as in a marathon or endurance race.  Interleukin-1b 
is thought to be produced locally within tissue, and therefore, it is suspected that the delayed 
response may reflect leakage into circulation upon tissue damage (Lamprecht et al., 2008).  Early 
studies demonstrated that exercise induced an increase in IL-1 (Cannon et al., 1986; Evans et al., 
1986); however, later it was realized that the biological assay used in early studies could not 
distinguish between IL-1 and IL-6 (Bagby et al., 1996, Ostrowski et al., 1998, Ostrowski et al., 
1999).  A study by Cannon et al. (1986) investigated the possibility that IL-1 secretion might be 
mediated by stress hormones associated with exercise.  The study showed that IL-1 secretion by 
monocytes increased by the addition of physiological concentrations of epinephrine in vitro as 
well as low levels of hydrocortisone.  However, higher concentrations in the physiological range 
did not affect, while combinations of epinephrine and hydrocortisone suppressed IL-1 secretion 
(Cannon et al., 1986).  Cannon et al. (1986) also reported that IL-1 activity appeared in plasma 
several hours after exercise on a cycle ergometer (1 h at 60% of aerobic capacity).  Similarly, 
urine levels of IL-1b increased until 12 h after long-distance running (Sprenger et al., 1992).  
One study investigated IL-1 levels after a 45-min bout of high-intensity eccentric exercise in 
trained vs. untrained men (Evans et al., 1986).  In the trained men, plasma IL-1 was higher than 





IL-1 was significantly elevated 3 h after exercise in the untrained men.  The results of this study 
suggest that training may affect IL-1b levels after exercise because eccentric exercise may lead 
to delayed muscle damage in untrained individuals (Evans et al., 1986).  Even though many 
studies have demonstrated elevated levels of IL-1 after exercise, there are other studies that 
found no changes or only slightly elevated levels of IL-1 in plasma post-exercise (Sprenger et al., 
1992; Ullum et al., 1994a; Drenth et al., 1995; Bruunsgaard et al., 1997; Nehlsen-Cannarella et 
al., 1997; Ostrowski et al., 1998).  These conflicting results are likely due to inconsistent 
variables in each study, such as mode and duration of exercise, as well as different gender and 
ages of participants. 
TNFa 
Inconsistent findings have been reported for TNFa responses to exercise (Ostrowski et 
al., 1998).  Dufau et al. (1989) and Espersen et al. (1990) reported increased plasma TNFa 2 h 
after completing a 2.5-h run and 1 h after a 5-km run, respectively, but other studies have failed 
to detect systemic TNFa after exercise (River et al., 1994, Ullum et al., 1994a, Ullum et al., 
1994b).  A study by Sprenger et al. (1992) showed elevated urine levels of TNFa immediately 
after 2 h of running, but a subsequent rapid decline to pre-exercise levels.  Conversely, Ostowski 
et al. (1998) was not able to detect TNFα mRNA in blood or muscle samples 2 h after a 
marathon race; similarly, Drenth et al. (1995) did not detect an effect of exercise on plasma 
concentrations of TNFa after a 6-h endurance run.  One of the few studies investigating TNFa in 
horses showed that exercise prompted significant increases in IL-1 and TNFa in blood and IL-
6 and TNFa in muscle following an incremental graded exercise test (GXT) on a treadmill (1 





or blood IL-6 following the GXT, and all pro-inflammatory cytokine levels in both blood and 
muscle returned to pre-GXT levels by 24 h post exercise.  This study concluded that high-
intensity exercise resulted in increases in the expression of inflammatory cytokines in both 
muscle and blood (Liburt et al., 2010). 
IL-6 
Interleukin-6 was initially thought to be a pro-inflammatory cytokine similar to IL-1, 
which may have resulted from the fact that early assays could not distinguish between IL-1 and 
IL-6.  Therefore, IL-1 and IL-6  were assumed to have similar functions. However, more recent 
studies have demonstrated that IL-6 is an inflammation-responsive cytokine rather than a pro- or 
anti-inflammatory cytokine, since IL-6 does not directly induce inflammation but increases in 
response to inflammation (Ostrowski et al., 1998, Pedersen 2000, Pedersen et al., 2000, 
Lamprecht et al., 2008).  Most of the literature agrees that IL-6 is produced both systemically 
and locally in the muscle, stimulated by muscle contractions (Pedersen 2000, Febbraio 2007).  
Contracting muscle releases IL-6 into circulation and affects fuel metabolism during exercise, 
contributing to glucose homeostasis by inducing hepatic glucose output and mediating lipolysis 
(Edwards et al., 2006, Febbraio 2007).  Interleukin-6 also helps regulate immune responses to 
exercise by directly inhibiting the expression of TNFa and IL-1 as well as up-regulating 
production and secretion of IL-10, which also inhibits TNFa and IL-1b production.  Interleukin-
6 may also have a stimulatory effect on the secretion of APPs, which are a critical factor in the 
APR (e.g., SAA; Heinrich 1990, Gleeson 2000).  In a review of exercise and cytokines by 
Pedersen (2000), the increase in IL-6 was described as closely related to the duration as well as 





Given that IL-6 is produced in large amounts in response to exercise, is produced locally 
in the skeletal muscle in response to contraction during exercise, and has growth factor abilities, 
IL-6 may likely be involved in and play a beneficial role in mediating exercise-related metabolic 
changes (Pedersen 2000).  The literature also suggests that muscle IL-6 output may act as a 
mechanism contributing to the development of fatigue in prolonged exercise (Gleeson 2000).   
Ostrowski et al. (1998) conducted a study in humans examining IL-6 concentrations in muscle 
and blood mononuclear cells (BMNC) before and after exercise to investigate the role of 
exercise-induced muscle damage and IL-6 production.  Before exercise, mRNA for IL-6 was not 
detected either in muscle or in BMNC but was detectable in muscle biopsies after exercise (not 
in BMNC), suggesting exercise-induced damage of skeletal muscle fibers may trigger local 
production of IL-6 (Ostrowski et al., 1998).  Supporting this finding, Gleeson (2000) reported 
that an active upper leg of humans released IL-6 into the circulation during prolonged single-
limb exercise, and not noted at all in the resting leg.  Based on this evidence, IL-6 is thought to 
be an indicator of skeletal muscle damage, primarily due to the significant increases in IL-6 
concentrations in blood and muscle that have been documented in human athletes following both 
dynamic eccentric and static resistance exercise. 
Even though IL-6 is one of the more commonly investigated cytokines when studying 
exercise stress, there are still conflicting results among the literature on its specific response to 
exercise, much like IL-1 and TNFa.  Interleukin-6 is commonly shown to be produced in more 
copious amounts than any other cytokine in relation to exercise in humans and is most 
commonly seen after strenuous exercise (Pedersen 2000, Edwards et al., 2006).  An early study 
by Northof et al. (1991) showed increased levels of IL-6 after a marathon.  This finding of 





et al., 1994a; Drenth et al., 1995; Nehlsen-Cannarella et al., 1997; Castell et al., 1997; Rohde et 
al., 1997; Hellsten et al., 1997; Bruunsgaard et al., 1997; Ostrowski et al., 1998).  Sprenger et al. 
(1992) conducted a study investigating cytokine levels in trained runners after a 20-km run.  The 
study did not detect most of the investigated cytokines in plasma except for IL-6; however, only 
urine samples were analyzed.  The IL-6 levels in urine were shown to increase until 7 h after the 
long-distance run (Sprenger et al., 1992).  A study testing the hypothesis that the exercise-
induced increase in circulating cytokine levels was associated with muscle damage showed that 
serum IL-6 increased after eccentric exercise and was correlated significantly to creatine kinase 
(CK; a marker of muscle damage) concentration in the following days, but changes were not 
noted after concentric exercise (Bruunsgaard et al., 1997).  A slightly different result was 
reported by Edwards et al. (2006) in which the IL-6 response to two different intensities of 
exercise was investigated.  Interleukin-6 increased above baseline immediately after the maximal 
exercise bout but not the submaximal exercise.  However, IL-6 levels did increase at 30 and 60 
min after exercise of both intensities, showing that 45 min of moderate-intensity exercise can 
increase IL-6, however, the inclusion of maximal effort may accelerate this response (Edwards et 
al., 2006). 
Given the facts that IL-6, more than any other cytokine, is produced in large amounts in 
response to exercise, that IL-6 is produced locally in the skeletal muscle in response to exercise 
and that IL-6 is known to have growth factor abilities, it is likely that IL-6 plays a beneficial role 
and may be involved in mediating exercise-related metabolic changes (Pedersen 2000).  
However, similar to IL-1b and TNFa, dysregulated or continual synthesis of IL-6 has the 






Interleukin-10 is an anti-inflammatory cytokine that has been shown to inhibit the release 
of TNFa and IL-1 and induce the production of IL-1ra (Jenkins et al., 1994; Cassatella et al., 
1994, Chernoff et al., 1995, Ostrowski et al., 1999, Rossio, 1999). It is suggested that IL-10 
increases after strenuous exercise to mediate the resulting inflammatory response.  A study 
investigating plasma levels of IL-10 after a 3-h marathon showed a 27-fold increase immediately 
post-exercise (Ostrowski et al., 1999).  Similar results by Nieman et al. (2005) reported a 160-km 
run induced a 24x increase in IL-10 and 125x increase in IL-6, along with correlated levels of 
creatine phosphokinase (CPK).  This study suggested that the increases of IL-6 and IL-10 post-
exercise might serve as a check to exercise-related inflammatory responses to prevent chronic 
conditions.  A similar response was also seen noted by Lamprecht et al. (2009), where IL-6 and 
IL-10 were significantly elevated following a marathon race when compared with resting values 
and remained elevated up to 4 h into the recovery phase.  A majority of studies investigating IL-
10 used long duration or eccentric exercise under the assumption that IL-10 raises in response to 
stress or inflammation triggered by exercise-induced tissue damage.  However, a study by 
Conroy et al. (2016) determined that regular aerobic exercise (submaximal) did not alter basal 
levels of interleukin IL-10.  Another study focused on assessing the effects of exercise training 
on biomarkers of inflammation in postinfarction patients and found that exercise-training 
moderately improved IL-10 levels when compared to a sedentary group of patients (Ribeiro et 
al., 2012).  It should be noted that even though the difference was statistical, the change in values 
was numerically small and, therefore, may not have had physiological implications.  However, 
the study still concluded that exercise training somewhat improved the inflammatory profile in 
post-myocardial infarction patients by enhancing the anti-inflammatory cytokine IL-10 (Ribeiro 





exercise in humans, and even less research has been conducted in horses.  Much more work is 
needed to investigate differences in IL-10 response to various exercise modalities and intensities, 
as well as more thoroughly investigating the role of IL-10 in performance horses.  Because it is 
an anti-inflammatory cytokine, increasing IL-10 production could be beneficial in helping 
regulate inflammation, especially after exercise. 
In conclusion, previous literature has primarily focused on cytokine responses to 
eccentric exercise.  Overall, increases in the pro-inflammatory cytokines, TNFa and IL-1, and a 
dramatic increase in the inflammation responsive cytokine, IL-6, were noted after strenuous 
aerobic exercise, such as a marathon (Ostrowski et al., 1999, Nieman et al., 2005, Gleeson 2007).  
This influx of cytokines was balanced by a release of cytokine inhibitors (IL-1ra) and the anti-
inflammatory cytokine, IL-10 (Ostrowski et al., 1999, Gleeson 2007).  However, many studies 
are still in disagreement on how pro and anti-inflammatory cytokines specifically respond to 
exercise.  There are several possible explanations for the variability in response to exercise in 
cytokines.  One difficulty in interpreting the literature is the varying types of physical activity, as 
well as the intensity and duration of the exercise between studies.  In addition, there is increasing 
recognition that individual difference factors, such as training status, age, and sex, may affect the 
inflammatory response to exercise (Edwards et al., 2006).  Currently, the effect of age on 
cytokine expression after exercise has not been thoroughly investigated and could play a role in 
the differences reported between studies, as growth may contribute to systemic inflammation and 
stress. 
Despite numerous studies evaluating cytokine changes in response to different modes and 
intensities of exercise in humans, there has been limited work of this nature completed in horses.  





subsequent to exercise as characterized by increased expression of mRNA for TNFa, IL-1b, and 
IL-6 in peripheral blood mononuclear cells, as well as IL-6 in muscle (Nieman et al., 2005, 
Liburt et al., 2010, Horohov et al., 2012).  Another study conducted by Lamprecht et al. (2008) 
measured pro-inflammatory and anti-inflammatory cytokine transcripts in the whole blood of 
Standardbred mares after exercise and noted that pro-inflammatory cytokine transcripts were 
elevated after exercise.  Another study in horses demonstrated that mRNA expression for 
inflammatory cytokines increased following exercise and suggested that those markers of 
inflammation may play a role in delayed onset muscle soreness (Liburt et al., 2010).  More 
research is needed investigating the role of pro- and anti-inflammatory cytokines as markers of 
systemic inflammation and stress and their response to exercise to be able to manage and 
maintain working horses properly. 
Cortisol 
Exercise has been shown to increase the concentrations of hormones in the blood, 
including (but not limited to) epinephrine, norepinephrine, and cortisol (Pedersen et al., 2000).  
Exercise-induced plasma cortisol concentrations have been extensively documented in both 
humans and horses; however, it should be noted that some of the literature conflicts or disagrees 
with what types of exercise cause increases in serum cortisol.  In most studies, increased serum 
cortisol is reported after excessive or intense exercise (Smith 2003).  Other studies show that 
cortisol mostly increases during long-duration exercise (Galbo 1983, Pedersen et al., 2000).  
Another study in humans showed that serum cortisol concentrations were elevated above control 
levels for several hours following prolonged running at high-intensity (Nieman, 1999).  
However, the most commonly accepted relation of cortisol level and exercise is that cortisol 





2002, Starkie et al., 2005, Gordon et al., 2006).  Moreover, levels of cortisol increase at a rate 
relatively proportional to the exercise intensity, but the maximum level is dependent upon the 
total duration (time) of the exercise session (Marc et al., 2000, McKeever 2002, Starkie et al., 
2005, Gordon et al., 2006).  
These studies observed that substantial increases in plasma cortisol occur in response to 
high-intensity exercise; however, moderate increases were still evident during submaximal or 
moderate exercise (Marc et al., 2000, Smith, 2003, Gordon et al., 2006).  In a study investigating 
both submaximal and maximal exercise, cortisol increased in both compared to the control 
condition, but the increase was greater after maximal exercise than submaximal exercise.  
Further results investigating cortisol in response to different exercise intensities in humans 
supported the view that moderate to high-intensity exercise provokes increases in circulating 
cortisol levels (Hill et al., 2008).  However, this study is one of the few looking at the response 
of cortisol to low intensity exercise (40% VO2max).  After corrections for plasma volume 
reduction and circadian factors, researchers reported that low-intensity exercise resulted in a 
reduction in circulating cortisol levels (Hill et al., 2008).  Lastly, a study comparing young and 
old horses reported that, while cortisol concentrations increased in both young and adult horses 
after exercise, younger horses had higher concentrations after exercise than older horses.  This 
finding may be a result of the stress of natural growth and might affect the overall levels of 
cortisol in young horses after exercise. 
Reliable physiological markers for performance evaluation in sport horses are missing.  
However, cortisol has been investigated as a potential biomarker for stress in horses after 
exercise (Marc et al., 2000).  Cortisol likely serves as a signal for cellular repair following a 





permissive effect that is beneficial for training adaptation by preventing the immune system from 
eliciting an excessive inflammatory and immune reaction to acute exercise (Smith, 2003, 
Edwards et al., 2006, McKeever et al., 2014).  Further, excessive increases in plasma cortisol 
concentrations immediately after exercise followed by disproportionately low plasma cortisol 
may be a marker of overtraining in horses (Davitt et al., 2014).  Additionally, cortisol has been 
linked to some of the immunosuppressive changes experienced during recovery. Glucocorticoids 
(i.e., cortisol) administered to humans in vivo have been reported to cause neutrophilia, 
eosinopenia, lymphocytopenia, and suppression of both NK and T-cell function, all of which 
occur during recovery from prolonged, high- intensity, cardiorespiratory exercise (Nieman, 
1999). Therefore, studies have suggested that high levels of cortisol may play a role in 
immunosuppression sometimes seen in athletes (Nieman, 1999).   
Serum Amyloid A 
  Acute phase proteins have been described in human and animal patient studies as a useful 
tool for assessing health, as they closely reflect the APR (Cywińska et al., 2012).  In horses, SAA 
level has been shown to increase from baseline levels from 10 to 1000 times in response to 
stressors such as inflammatory disorders or developing complications after surgical procedures, 
and may be useful in disease diagnostics and prognostication (Jacobsen et al., 2005, Jacobsen et 
al., 2007, Canisso et al., 2014).  However, there is less known about the relation between APPs 
like SAA and less severe stressors such as exercise or musculoskeletal  injury.   Serum amyloid 
A is considered a sensitive APP and may be an accurate marker of subclinical inflammation or 
even repetitive microtrauma that may play a role in overtraining syndromes.  A study in 
Thoroughbred racehorses showed that training-induced muscle, skeletal and joint trauma might 





amyloid A (SAA) (Turło et al., 2015a).  Results showed that mean levels of SAA within the first 
4 days of muscle and tendon injuries were significantly higher when compared to bone fractures, 
dorsal metacarpal disease, joint trauma, and healthy horses (control; Turło et al., 2015a).  
Researchers concluded that strain injuries of muscle and tendons could cause a moderate 
increase in SAA blood concentration in racehorses, reflecting the occurrence of the acute phase 
response.  In comparison, bone, metacarpal, and joint injuries did not show as substantial of an 
increase in SAA (Turło et al., 2015a).  Even though the cause of this difference has not yet been 
determined, it is assumed the lower mass of affected hard tissues and their reduced vasculature 
may be a limiting factor for the release of locally produced pro-inflammatory mediators, like IL-
6, to the bloodstream.  Injuries of muscle and tendon related to mechanical stress associated with 
race training can affect the serum level of SAA and should be considered in the interpretation of 
this biomarker in racehorses (Turło et al., 2015a).  Another study conducted by Turło et al. 
(2015b) reported that racehorses with stress-related injuries of the musculoskeletal  system 
showed higher SAA levels than non-injured horses on the 3rd and 4th day after the race and that 
SAA concentration correlated positively with white blood cell count.  Once again, it was 
suggested that racing effort might cause an increase in SAA level, but may be more pronounced 
in horses showing clinical signs of orthopedic injury after the race (Turło et al., 2015b).  
Regardless of injury, small, but noteworthy increases in SAA have been detected post-
intense exercise in horses (McGowan et al., 2014).  A study in endurance Arabians showed that 
after long-distance rides, the level of SAA markedly increased (Cywińska et al., 2012).  Another 
study in Arabians by Cywińska et al. (2013) investigated the difference in SAA response to 
endurance training.  The study showed that experienced (conditioned) horses, trained and 





endurance ride.  However, in contrast, there was a significant increase in SAA concentration 
(compared to resting levels) in horses in early training (only prepared for moderate distance 
rides) that underwent the same effort.  It was noted that more research is needed to deduce 
whether the difference in SAA seen indicated over-training or an adaptation to an increasing 
workload (Cywińska et al., 2013). 
 In conclusion, SAA could be used as a sensitive biomarker for detecting levels of 
inflammation in horses after exercise and may even play a role in accurately detecting 
musculoskeletal  injuries.  More research needs to identify the influence of differing degrees of 
exercise on SAA levels, as most of the research reported is in intense exercise (racehorses).  
There is also little information regarding the influence of training on SAA levels post-exercise, 
which could be beneficial in identifying SAA’s potential role in exercise-induced adaptations. 
Biomarkers in Response to Exercise 
In response to acute exercise (the most frequently studied area of exercise immunology), 
a rapid interchange of immune cells between peripheral lymphoid tissues and the circulation 
occurs (Nieman, 1999).  The extent of the response depends on many factors, including the 
intensity, duration, and mode of exercise, which can each affect concentrations of hormones and 
cytokines.  In general, acute exercise bouts of moderate length (< 60 min) and intensity (< 60% 
VO2max) are associated with fewer perturbations and less stress to the immune system than 
prolonged, high-intensity sessions.  All previously described biomarkers (cortisol, SAA, IL-1, 
IL-6, IL-10, and TNFa) are described extensively in the literature as markers of stress and 
inflammation appear to at least increase after high-intensity or long duration exercise, and some 






Human literature suggests that a heavy schedule of training and competition may lead to 
immunosuppression in athletes, placing them at a higher risk for opportunistic infection and 
overall immune system dysfunction (Bishop et al., 1999).  As a part of the immune response, 
inflammation is beneficial because disruptions of homeostasis to repair tissue injury permit 
stress-induced cellular adaptations.  It is generally accepted that an inflammatory response is 
beneficial when moderate and controlled (e.g., protecting against infection), but can become 
detrimental if dysregulated (Medzhitov, 2008).  Prolonged or exaggerated stress responses has 
been shown to potentially perpetuate hormonal dysfunction, widespread inflammation, and 
chronic pain (Hannibal et al., 2014).  Additionally, an unresolved inflammatory response can 
become counterproductive and exacerbate, rather than amend, the underlying problem, as in 
instances of overuse syndromes or repeated injuries (Cooper et al., 2007).  Unregulated 
inflammation can manifest as swelling, pain, and loss of function and chronic inflammation can 
lead to excessive collateral damage and unnecessary cellular damage (Chandrasoma et al., 1998, 
Ashley et al., 2012., Chovatiya et al., 2014).  Severe chronic inflammation has even been shown 
to induce symptoms such as malignant cell transformation in surrounding tissue, and septic 
shock (Landskron et al., 2014).  Thus, the timely resolution of inflammation is imperative.  Due 
to the interplay of inflammation and the immune system, the immune-suppressing effects of 
long-duration or intense exercise, and the need for the timely resolution of inflammation, 
immune boosting and anti-inflammatory dietary additives have been a topic of interest in both 
human and equine research (Paulsen et al., 2010). 
Strenuous exercise is known to suppress the immune system, and nutritional supplements 
have been proposed to boost post-exercise immunity, as nutrition is a critical determinant of 





effective (Carpenter et al., 2012).  Nutrient availability has the potential to affect almost all 
aspects of the immune system because the majority of immune responses involve cell replication 
or the production of proteins with specific functions (e.g., cytokines) and most nutrients are 
involved in protein synthesis (Kubena et al., 1996, Bishop et al., 1999).  Horse owners and 
trainers often look to dietary supplements to enhance the performance of their horses (Pratt-
Phillips et al., 2014).  However, anecdotal reports and media have often misled well-meaning 
equestrians by promoting various vitamins and minerals for their claimed performance benefits.  
However, people are often unaware that micronutrient supplementation is only beneficial when 
correcting a deficiency.  Currently, there is little scientific evidence to substantiate claims of 
micronutrients acting as an ergogenic aid (a substance that increases or improves work 
performance) outside of correcting an already existing deficiency.  However, there is thorough 
research demonstrating that excessive intakes of specific vitamins and minerals can be toxic 
(e.g., selenium in horses; Bishop et al., 1999).  Therefore, current research has turned to the 
investigation of other potential dietary additives. 
Saccharomyces cerevisiae 
Dietary beta-glucans (BG) have received significant attention as a nutritional additive 
because of their suggested modulatory properties of the immune system and inflammation.  Beta-
glucans are carbohydrates composed of glucose molecules linked together by several different 
types of chemical linkages, resulting in either a linear or branched structure.  Cereal grain BG 
(oats and barley) have a linear structure, while BG from fungal sources (mushrooms and yeast) 
have a 1,3/1,6 linkage pattern with varying degrees of side-chain branches.  The frequency and 
length of side-chain branches have important implications for biological activity, with the higher 





cerevisiae (SC), a type of yeast, which is shown to have a significant degree of side-chain 
branching and high antioxidant effects (Carpenter et al., 2012, Evans et al., 2012). The addition 
of direct-fed microbes (like SC) to manipulate the activities of the microbial population in the 
intestinal ecosystem has been investigated in both human and animal trials to investigate its 
ability to boost the immune system and subsequently reduce inflammation. Studies reported that 
the number of symptomatic illness or infection days were reduced in human adults supplemented 
with SC when compared with the placebo group (Moyad et al., 2010, Carpenter et al., 2012).  
However, it should be noted that some studies have mixed results due to the type of BG used, 
which may have structural differences when derived from different sources. 
Medina et al. (2002) investigated the effect of supplementation of SC on the response to 
high-fiber (HF) and high-starch (HS) diets in horses.  Supplementation of SC appeared to modify 
pH, concentrations of lactic acid and ammonia, molar percentages of acetate and butyrate with 
the HS diet and [(acetate + butyrate)/propionate] ratio when the HF diet was fed.  Also, when the 
digestion of starch in the small intestine was at capacity, SC supplementation appeared to limit 
the extent of undesirable changes in the intestinal ecosystem of the horse (Medina et al., 2002).  
Additionally, other studies in horses showed that yeast supplementation improved cell-wall 
digestibility (Jouany et al., 2008) and limited hindgut dysbiosis (microbial imbalance; Jouany et 
al., 2009). 
Many of the studies investigating SC fed to horses have focused primarily on digestion, 
however, work in humans and other species have demonstrated immune effects of SC 
supplementation.  Carpenter et al. (2012) evaluated whether 10 days of supplementation with a 
defined source of baker's yeast BG could minimize post-exercise immunosuppression.  The key 





inflammatory monocyte concentrations after exercise, increased LPS-stimulated production for 
certain cytokines before exercise, and increased plasma cytokine concentrations after exercise.  It 
was concluded that BG supplementation maintained blood monocyte circulation and countered 
the monocytopenia (low levels of monocytes) observed in the placebo group post-exercise 
(Carpenter et al. 2012).  It should be noted here that no notable differences were found between 
supplemented and non-supplemented groups for the LPS-stimulated production of IL-1𝛽, IL-6, 
IL-10, or TNF𝛼 (Carpenter et al., 2012). 
Yeast Fermentation Products 
Byproducts of yeast fermentation have been the focus of many studies (Glade et al., 
1990, Morgan et al., 2007, Moyad et al., 2010, Evans et al.2012, Zhang et al., 2013, Zhu et al., 
2017) because of their potential to have similar effects as the yeast itself.  Previous work has 
shown minimal to no adverse side effects with supplementation of an SC fermentation product 
(Glade et al., 1990, Medina et al., 2002, Morgan et al., 2007, Moyad et al., 2010, Zhang et al., 
2013, Zhu et al., 2017), indicating its safety as a dietary supplement.  Further, supplementation 
with a Saccharomyces cerevisiae (type of yeast) fermentation product (SCFP) appeared to 
provide both moderate immune-enhancing and anti-inflammatory benefits, demonstrating the 
potential to favorably modulate immune responses without excessive suppression or stimulation 
of overall immune activity (Carpenter et al., 2012, Evans et al., 2012). 
In humans, supplementing with a dried fermentation product (DF) notably reduced the 
incidence and duration of cold- and flu-like symptoms during fall and winter months, regardless 
of influenza vaccination status (Moyad et al., 2010).  It was suggested that a potential mechanism 
of action was enhanced salivary IgA production, NK cell activation, and increased antioxidant 





examine the ability of DF (EpiCor) supplementation to prevent or reduce inflammation in rats 
after receiving a 1% carrageenan injection in a paw (localized inflammation model) and 2) to 
examine the ability of DF to treat established inflammation induced by type-2 collagen in mice 
over 4 weeks (autoimmune arthritis model).  After all the rats got the carrageenan injection, the 
DF supplemented group showed significantly reduced swelling at all time points post-injection 
(1, 2, 3, 6, 12, and 24 h) when compared to the non-supplemented control group.  Additionally, 
edema severity and prostaglandin E2 (PGE2) levels were reduced by approximately 50% and 
25%, respectively.  In the second half of the study, DF supplementation significantly reduced 
arthritis scores, antibody response to type-2 collagen, and interferon-gamma levels compared to 
controls.  These results suggested that DF favorably impacted multiple acute and potentially 
chronic immunologic inflammatory control mechanisms and should be further tested in clinical 
trials (Evans et al., 2012).  Another study in rats focused on the ability of a yeast fermentation 
product (EpiCor) to mitigate heat stress.  Heat stress can result in a multitude of biological and 
physiological responses that can become lethal if not properly managed (Ducray et al., 2016).  
The trial exhibited that both villi height and total mucosal thickness in the small intestine 
decreased in heat-stressed rats after subjection to heat stress by more than 200µl in un-
supplemented rats.  However, oral treatment of rats with the fermentation product before heat 
stress prevented the traumatic effects on the intestine, indicated by no change in villi height or 
mucosal thickness after subjection to heat stress (Ducray et al., 2016).  Treatment with the 
supplement was also successful in the prevention of LPS release into the bloodstream of the 
heat-stressed rats (Ducray et al., 2016).  Elevation of body temperature also increased the 
concentration of vesicles released by the shedding of erythrocyte membranes, an indication of a 





yeast fermentation product protected erythrocytes from the heat-induced pathology (Ducray et 
al., 2016).  Finally, exposure to heat stress conditions resulted in considerable increases of white 
blood cells in rats, except in those treated with the supplement before heat stress, whose white 
blood cell count remained the same as in non-heated controls.  The results of this study showed 
the protective effect of yeast fermentation product in the prevention of complications, caused by 
heat stress (Ducray et al., 2016). 
Research in chickens has also shown favorable effects of supplementation of yeast 
fermentation products.  Functional metabolites of Diamond V Original XPCTM (Diamond V 
Mills, Cedar Rapids, IA), an SC fermentation product, helped balance the immune response and 
stress hormone levels in production poultry (Firman et al., 2013, Price et al., 2018).  Heat stress 
in commercial broiler chickens can lead to cellular oxidative stress, which increases 
susceptibility to infectious diseases (Price et al., 2018).  Price et al. (2018) demonstrated that 
birds fed XPC had a reduced negative response to heat stress as indicated by both lower plasma 
corticosterone concentrations and lower composite physical asymmetry scores (Price et al., 
2018).  The reduction in stress susceptibility observed by Price et al. (2018) combined with 
immune modulation observed by Chou et al. (2017) may explain why other studies have shown 
increased growth and feed conversion in birds fed XPC (Gao et al., 2008, 2009).  Chickens 
supplemented with XPC had increased secretory IgA and intestinal IgM, and there was a positive 
impact of XPC supplementation on weight gain, feed conversion, and mortality (Gao et al., 2008, 
2009).  Similar results were noted by Al-Mansour et al. (2011), who showed that XPC decreased 
heterophil/lymphocyte ratios considerably in supplemented broiler chickens.  Guo et al. (2013) 
also investigated the effects of an SC fermentation product on dairy cattle performance.  Results 





However, cows receiving the XPC supplement had reduced levels of SAA (Guo et al., 2013), 
demonstrating that SCFP attenuated the inflammatory effect of the SARA challenge.  Another 
study in dairy cattle showed that supplementation increased lactation performance of dairy cows 
and tended to reduce LPS concentration in plasma on two different farms (Zhang et al., 2013). 
In horses, yeast fermentation supplementation has been investigated for both increased 
digestibility of foodstuffs and athletic performance enhancement (Glade et al., 1990, Medina et 
al., 2002, Wickler, 2002, Morgan et al., 2007, Grimm et al., 2016). Previous research has shown 
that yeast fermentation products may be stimulatory to equine hindgut digestion and can 
beneficially alter microbial population (Medina et al., 2002, Morgan et al., 2007, Grimm et al., 
2016), which may help improve nutrient digestibility, increase microbial populations, and 
maintain cecal pH.  Improving the digestibility of lower-quality forages could be advantageous 
both for the horse’s health as well as for the producer.  In a study by Morgan et al., dry matter, 
crude protein, and NDF digestibilities of low-quality hay were greater in horses fed a yeast 
culture supplement than un-supplemented horses, demonstrating improved digestibility of lower-
quality Bermudagrass hay in mature horses.  Glade et al. (1990) investigated the same 
supplement related to athletic performance in Arabian horses.  The study demonstrated that 
horses supplemented with a yeast culture had significantly lower heart rates during the first 5 and 
the last 10 min of 35-min exercise bouts as well as numerically lower plasma lactate levels than 
non-supplemented horses, suggesting an enhanced state of athletic fitness (Glade et al., 1990).  
Also, initial increases in plasma triglyceride concentrations tended to be slower in the 
supplemented group than in the non-supplemented group, suggesting that fatty acid clearance 
from the plasma may have become more efficient, potentially via uptake by working muscle 





(an SC fermentation product) on submaximal performance in Arabian endurance horses.  Results 
showed a substantial increase in blood FFA, glucose, hemoglobin, and packed cell volume, 
demonstrating the potential ability of XPC to improve submaximal performance in horses 
(Wickler 2002). 
Dietary Intervention of Yeast Products 
In conclusion, yeast fermentation products favorably impact multiple acute and 
potentially chronic immunologic inflammatory control mechanisms and should be further tested 
in future trials.  Although the mechanisms of action for yeast and yeast fermentation products are 
unknown, some suggest effects are due to its high antioxidant content.  Evans et al. (2012) 
suggested that the yeast fermentation product used in his study contained a high concentration of 
metabolites and numerous and diverse free radical scavenger compounds, exemplified by its high 
antioxidant content as shown in an oxygen radical absorbance capacity (ORAC) assay.  
Supplementing with a fermentation product (i.e., Epicor in humans and XPC in animals) has 
demonstrated the potential to favorably modulate immune responses without excessive 
suppression or stimulation of overall immune activity while having minimal adverse events.  The 
interplay of the various compounds involved in immune activity suggests that modulation rather 
than excessive reduction or stimulation would explain some of the clinical findings with yeast 
product supplementation.  Given this information, further investigations of yeast products should 
be conducted to better understand the areas where SC may continue to provide beneficial results 
(Evans et al., 2012), specifically research investigating SC fermentation products in horses and 





CHAPTER III  
MATERIALS AND METHODS 
This study was reviewed and approved by the Institutional Animal Care and Use 
Committee at Texas A&M University (2016-0294). 
Horses 
Nineteen previously untrained Quarter Horses (11 fillies, 8 colts) entering their yearling 
year (mean ± SD; age: 9 ± 1 mo) with a starting BW of 266 ± 32 kg were enrolled in the 8-wk 
study. Horses originated from two sources: 8 were from the Texas A&M University (TAMU) 
horse center herd (College Station, TX) and 11 were leased from Birdsong Farms (Hearne, TX). 
Horses originating from Birdsong Farms were relocated to Freeman Arena prior to the beginning 
of the trial, and all horses remained there throughout the 8-wk trial. Horses were group-housed 
by gender and farm of origin (TAMU colts/TAMU fillies/Birdsong colts/Birdsong fillies) at 
Texas A&M University’s Freeman Arena (College Station, TX) in approximately 0.5-hectare dry 
lots. All horses received a basal diet consisting of a commercial grain mix custom-formulated 
with no yeast fermentation products at 1.25% BW (DM basis) split into 2 equal meals per day, 
and Coastal bermudagrass hay fed ad libitum in dry lots devoid of fresh forage. The basal diet 
was formulated to meet or exceed the requirements of growing horses (NRC, 2007). Composited 
hay and grain samples were analyzed for nutrient composition prior to the initiation of the trial 
and are presented in Table 1. All horses received the basal diet (hay + grain) for 4 wk prior to the 
start of the trial. At wk 0, horses were stratified by age, sex, BW, and farm of origin and 
randomly assigned to one of two groups: 1) no supplementation (CON; n = 9) or 2) 





Diamond V Mills, Inc.; SCFP; n = 10) split into 2 equal feedings. The supplement was top-
dressed on the SCFP horses’ grain at each feeding (10.5 g/feeding). 
Dietary Treatment 
During the study, horses were hand walked into individually assigned 3.2 x 3.2 m stalls 
twice daily to receive their concentrate grain meal. Concentrate grain was split equally into AM 
and PM meals at 0600 and 1700, respectively. Any refused grain was weighed and recorded 
daily and subtracted from the total grain offered to obtain accurate grain consumption of each 
horse. All horses received ad libitum access to Coastal bermudagrass hay which was supplied in 
the form of a round bale. Individual hay intake was calculated from estimated intake while 
group-housed. Group-housed estimates were obtained from the disappearance of known 
quantities in each dry lot, were assumed to be equal among all horses in each group, and resulted 
in an average hay intake of 1.5% BW (DM basis) for each horse. Throughout the study, BW was 
monitored every 2 wk using a livestock scale accurate to 1 kg (Cardinal scales, Webb City, MO). 
Body condition score was also evaluated on the same day BW was measured by three 
independent investigators using the 1 to 9 scale described by Henneke et al. (1983). Grain 
offered was adjusted for each horse every 2 wk based on changes in BW due to growth and to 










Table 1. Nutrient composition of custom-formulated concentrate and Coastal 



















1 Values presented on a 100% DM basis. 
2 Concentrate = basal grain diet fed to all horses at 1.25% of Body Weight (BW) in Dry Matter 
(DM) per Day 
3 Coastal bermudagrass hay fed ad libitum to all horses 
 
 
Nutrient1 Concentrate2 Coastal Hay3 
DE, Mcal/kg 0.61 0.39 
CP, % 18.0 13.0 
ADF, % 15.2 40.3 
NDF, % 30.4 71.6 
Starch, % 18.0 1.00 
Crude Fat, % 8.40 1.70 
Ca, % 1.40 0.44 
P, % 1.06 0.22 
Mg, % 0.57 0.17 
K, % 1.40 0.88 
Na, % 0.62 0.30 
Cl, % 1.08 0.52 
S, % 0.30 0.24 
Fe, ppm 813 184 
Zn, ppm 217 34.0 
Cu, ppm 56.0 7.00 
Mn, ppm 189 241 





Submaximal Exercise Test 
Following 8 wk on dietary treatments, all horses underwent a 2-hr submaximal exercise 
test (SET) on an 8-horse Panel Walker, measuring approximately 21 m in diameter (Priefert 
Manufacturing, Mount Pleasant, TX). The exercise test consisted of 8 replications of walking at 
1.3 m/s for 3 min (24 min total), trotting at 3.1 m/s for 7 min (56 min total), and cantering at 5.4 
m/s for 5 min (40 min total). Midway through the SET, horses reversed direction, and the second 
half of the SET was completed traveling in the opposite direction (1 hr per direction). To allow 
for accurate sampling, horses were balanced by treatment group, sex, and barn of origin and 
randomly assigned to one of three exercise groups. The SET was performed over three 
consecutive days and started at 0800 each day. Average temperature over the three days was 
11.7°C with 83% relative humidity.  
Sample Collection 
Blood samples were collected at wk 0 and 8 pre-SET at 0500 prior to receiving any 
concentrate. Blood was also collected immediately after the SET (0 hr), and 1 and 6 hr after the 
SET at 1000, 1100, and 1600, respectively. Approximately 30 mL of blood was collected from 
each horse via venipuncture from the jugular vein into evacuated tubes (Vacutainer; Becton, 
Dickson and Co., Franklin Lanes, NJ). Tubes contained either no anticoagulant for serum 
collection or sodium heparin for plasma collection.  Serum and plasma were isolated within 2 hr 
of collection, aliquoted, and stored at -80°C until analysis. Serum samples were analyzed for 
serum cortisol and serum amyloid A (SAA) concentrations using commercially available kits 
(cortisol: DetectX® Cortisol Immunoassay Kit, Arbor Assays, Ann Arbor, MI; SAA: Horse 
Serum Amyloid A (SAA) ELISA Kit, Innovative Research, Inc., Novi, MI). Each kit provided a 





according to the manufacturer’s recommendations. For cortisol, serum was diluted 1:100 with 
the diluent provided in the kit. Samples with very low cortisol concentrations were diluted 1:25 
with kit diluent and values were then divided by 4. For SAA serum was diluted 1:200 with the 
provided diluent. For both assays, the absorbance (450 nm) of the contents of each well was 
immediately determined using a plate reader. All samples were analyzed in triplicate. The 
interassay and intraassay CV were 8.5% and 5.3%, respectively, for cortisol and 2.2% and 4.5%, 
respectively, for SAA. 
Statistical Analysis 
One CON horse was dismissed from the SET due to lameness unrelated to the study and 
was not included in statistical analyses. Data were analyzed using PROC MIXED in SAS v9.4 
with repeated measures (time). Diet, time, and the diet ×	time interaction were included as fixed 
effects and horse within diet was included as a random effect. Data were tested for normality and 
log-transformed prior to analysis if not normally distributed. The responses to diet (wk 0 to wk 8 
pre-SET) were analyzed separately from the response to the wk 8 SET. All data are expressed as 







CHAPTER IV  
RESULTS 
Serum cortisol decreased from wk 0 to 8 (P = 0.014) in both groups but was unaffected 
by diet (Fig. 1A).  Serum amyloid A was also similar between treatment groups but did not 




Figure 1A. Serum cortisol concentrations of yearling Quarter Horses before (wk 0) and after (wk 
8 pre-SET) 8 wk of receiving basal grain diet only (CON; n = 8) or basal grain diet plus 21 g 
Saccharomyces cerevisiae fermentation product (SCFP; n = 10) per day. Overall effects of 
































Figure 1B. Concentrations of serum amyloid A (SAA) of yearling Quarter Horses before (wk 0) 
and after (wk 8 pre-SET) 8 wk of receiving basal grain diet only (CON; n = 8) or basal grain diet 
plus 21 g Saccharomyces cerevisiae fermentation product (SCFP; n = 10) per day. Overall 
effects of dietary treatment (P = 0.217), time (P = 0.223), and treatment ´ time (P = 0.640). 
 
In response to the wk 8 SET, serum cortisol increased in both groups immediately after 
the SET (0 hr post-SET; P≤0.0005) but returned to pre-SET levels in SCFP by 1 hr post-SET 
(Fig. 2A).  At 6 hr post-SET, cortisol in CON had returned to pre-SET concentrations, while 
SCFP declined to be lower than pre-SET (P = 0.0001) and lower than CON (P = 0.01) at that 
time point (Fig. 2A).  Serum amyloid A increased at 6 hr post-SET in CON (P < 0.0001) but was 
unchanged through 6 hr post-SET in SCFP (Fig. 2B).  At 6 hr post-SET, SAA levels were 






























Figure 2A. Serum cortisol concentrations of yearling Quarter Horses before a 2-hr submaximal 
exercise test (Pre-SET), immediately post-SET (0 hr), and 1 hr, and 6 hr post SET following 8 
wk of receiving either a basal grain diet only (CON; n = 9) or basal grain diet plus 21 g 
Saccharomyces cerevisiae fermentation product (SCFP; n = 10) per day. Overall effects of 
dietary treatment (P = 0.316), time (P < 0.0001), and treatment ´ time (P = 0.057). a,b,c,x,y,z 












































Figure 2B. Concentrations of serum amyloid A (SAA) of yearling Quarter Horses before a 2-hr 
submaximal exercise test (Pre-SET), immediately post-SET (0 hr), and 1 hr, and 6 hr post SET 
following 8 wk of receiving either CON or SCFP diet. Overall effects of dietary treatment (P = 
0.316), time (P < 0.0001), and treatment ´ time (P = 0.057). a,b,c,x,y,z Within diet, different letters 





























CHAPTER V  
DISCUSSION 
Research exploring the inflammatory response to exercise in human athletes is prevalent. 
However, there is significantly less research investigating stress and inflammation in response to 
exercise in performance horses, especially young horses entering a training program. 
Inflammation is the body’s protective response to deviations or challenges to tissue homeostasis 
and is necessary for stress-induced cellular adaptations. However, the resolution of inflammation 
is imperative to prevent unnecessary cell damage (Landskron et al., 2014). Unresolved 
inflammation may manifest as swelling, heat, pain, and loss of function (Chovatiya et al., 2014) 
and result in symptoms as mild as delayed-onset muscle soreness or as severe as debilitating 
injuries affecting soft tissue, joint, and bone (MacIntrye et al., 1995, Smith 2004, Horohov et al., 
2012). Due to the interplay of inflammation and the immune system and the immune-suppressing 
effects of long-term or intense exercise, this study aimed to investigate a potential immune 
boosting and anti-inflammatory dietary additive for the preventative maintenance of young 
horses entering into an exercise training program. 
The present study demonstrated that horses receiving dietary supplementation with a 
Saccharomyces cerevisiae fermentation product (Original XPC; Diamond V Mills, Inc.) for eight 
weeks responded more favorably to a prolonged exercise bout than non-supplemented horses. 
Serum cortisol in SCFP horses returned to pre-SET concentrations more quickly after exercise 
compared to CON horses. Additionally, serum amyloid A, a sensitive marker of inflammation, 
was unaffected by exercise in supplemented horses, while increasing significantly 6 hr after 





Various mechanisms to improve the longevity of performance horses have been 
investigated, with an increased focus on the role of stress-induced immune and inflammatory 
responses (Horohov et al., 2012). In human and animal studies, yeast fermentation products have 
been shown to have potential benefits from reducing heat stress to enhancing the immune 
response (Moyad et al., 2010, Evans et al., 2012, Price et al., 2018). While less research is 
available documenting the effects of yeast byproduct supplementation in horses, some work has 
indicated positive outcomes of supplementation. In untrained, young horses, supplementation 
with a yeast culture decreased plasma lactate levels and delayed increases of plasma triglyceride 
levels following a treadmill exercise test compared to non-supplemented control horses (Glade et 
al., 1990). Supplemented horses also showed lower heart rates during the first 5 and last 10 min 
of the exercise test, suggesting enhanced athletic fitness in young horses prior to entering an 
exercise training program (Glade et al., 1990). Arabian endurance horses receiving a 
Saccharomyces cerevisiae fermentation product (Original XPC; Diamond V Mills, Inc.) for 8 wk 
showed improvement in submaximal performance as evidenced by a 15-80% increase in blood 
free fatty acids at all time points and an 8-10% higher level and less fluctuation of blood glucose 
during and after the exercise test when compared to the control group. Additionally, 
supplemented horses had a 5-9% increase in blood hemoglobin at all time points and a 3-9% 
increase in packed cell volume at all time points when compared to the non-supplemented group 
(Wickler 2002). Many trials have demonstrated favorable effects of supplementing with a yeast 
fermentation product; however, the impact of a yeast fermentation product on markers of stress 
and systemic inflammation in horses has not been thoroughly investigated. 
There are few known biomarkers that can quantitatively capture acute responses to stress. 





stressor and, importantly, serves as a signal for cellular repair following exercise (McKeever et 
al., 2014).  High levels of cortisol in the blood (hypercortisolism) can result in symptoms such as 
high blood pressure (Griffing 2014), potentially putting extra strain on the heart 
and blood vessels, which over time may increase the risk of heart attack or stroke (DeMarco et 
al., 2014). Long-term high blood pressure is also linked to heart and kidney disease (DeMarco et 
al., 2014). Excess cortisol is also associated with excessive tissue breakdown and increased 
blood glucose concentration (hyperglycemia; Griffing 2014), which if frequent or ongoing, can 
cause damage to nerves, blood vessels, and organs. Therefore, the ability of tissues to remove 
cortisol from circulation is essential to reduce the risk of bodily damage.  In the current study, all 
horses exhibited an increase in serum cortisol immediately following the SET (0 hr). However, 
SCFP returned to pre-SET levels more quickly and had significantly lower levels of serum 
cortisol at 6 hr post-SET than CON horses. These results suggest that horses receiving the 
Saccharomyces cerevisiae fermentation product may have been more efficient at removing 
cortisol from circulation than non-supplemented horses, which may lead to a decreased degree of 
damage following exercise. 
The use of APPs, especially serum amyloid A (SAA), to monitor acute immune 
responses is becoming more common in equine research as commercial diagnostic kits are being 
validated (Satoh et al., 1995, Crisman et al., 2008). Low or undetectable SAA levels in healthy 
horses combined with the sizable, rapid increase in plasma SAA after an inflammatory stimulus 
and a short half-life allows SAA to be efficiently used to closely monitor the course and 
treatment of inflammation (Jacobsen et al., 2007). In the current study, all horses had similar 
levels of SAA through 1 hr post-exercise. However, at 6 hr post-SET, CON horses had a 





significantly higher at 6 hr post-SET in CON than SCFP. The difference in SAA levels likely 
indicates that horses receiving supplement had a diminished inflammatory response after 
exercise when compared to control horses, suggesting that the Saccharomyces cerevisiae 
fermentation product mitigated inflammation after exercise. 
Systemic cytokine levels are an emerging area of interest when investigating exercise-
induced inflammation. Cytokines are activated by inflammatory stimuli and they affect many 
different cells and tissues throughout the body, and combinations of various cytokines on target 
cells may have a stimulatory or suppressive effect. As an example, the accumulation of SAA 
generally requires IL-6 and IL-1b or TNFa production, so multiple cytokines and inflammatory 
mediators must be observed simultaneously to obtain a complete picture of the overall 
inflammatory response (Crisman et al., 2008). In humans, strenuous exercise results in an 
increase in a concentration of cytokines, including TNFa, IL-1b, IL-6 (pro-inflammatory), and 
IL-10 (anti-inflammatory; Pedersen et al., 2000).  However, the type, intensity, and duration of 
physical activity have been shown to affect the cytokine profile differentially (Edwards et al., 
2006, Crisman et al., 2008). Cytokine profiles of the horses in the current study have yet to be 






CHAPTER VI  
SUMMARY 
The current study demonstrated that eight weeks of dietary supplementation with SCFP 
may mitigate stress following prolonged exercise in young horses. Decreased levels of SAA in 
the supplemented group of young horses suggests a lower level of systemic inflammation when 
compared to non-supplemented horses. Additionally, supplemented horses returned to baseline 
levels of cortisol quicker than control horses, suggesting that the supplemented horses may have 
been more efficient at recovering from the exercise stressor and clearing cortisol out of 
circulation than the control horses.  Given the results, the effects of SCFP on the exercise-
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